Related references
Note: Only part of the references are listed.Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
Guoxuan Gao et al.
BMC CANCER (2020)
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1
Preeti Narayan et al.
CLINICAL CANCER RESEARCH (2020)
Tissue-resident memory T cells in breast cancer control and immunotherapy responses
Ann Byrne et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
Zhiwei Hu
SCIENTIFIC REPORTS (2020)
CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer
Yasmin Vahidi et al.
BMC CANCER (2020)
KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer.
Javier Cortes et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Phase III randomized study of adjuvant treatment with the ANTI-PD-L1 antibody avelumab for high-risk triple negative breast cancer patients: The A-BRAVE trial.
Pier Franco Conte et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer
Luis Alberto Solis-Castillo et al.
BREAST CANCER (2020)
Targeting epidermal growth factor-overexpressing triple-negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
Yan Liu et al.
CELL PROLIFERATION (2020)
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer
Manuela Terranova-Barberio et al.
NATURE COMMUNICATIONS (2020)
Predicting therapeutic efficacy of endocrine therapy for stage IV breast cancer by tumor-infiltrating lymphocytes
Yuka Asano et al.
MOLECULAR AND CLINICAL ONCOLOGY (2020)
Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis
Yutian Zou et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
B cell and B cell-related pathways for novel cancer treatments
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2019)
Alteration of specific cytokine expression patterns in patients with breast cancer
Kosuke Kawaguchi et al.
SCIENTIFIC REPORTS (2019)
Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
Victor Sanchez-Margalet et al.
TRANSLATIONAL CANCER RESEARCH (2019)
Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
Karin M. Knudson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue et al.
CANCER SCIENCE (2019)
The Anti-tumoral Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGFβ1 Gene Expression in Pre-surgical Breast Cancer Patients
Sarvenaz Kashefi et al.
Iranian Journal of Allergy Asthma and Immunology (2019)
Nimbus: A phase II study of nivolumab plus ipilimumab in metastatic hypermutated HER2-negative breast cancer.
Romualdo Barroso-Sousa et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
Anna Glajcar et al.
VIRCHOWS ARCHIV (2019)
Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer
Emi Ishigami et al.
BREAST CANCER (2019)
High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer
Aura Muntasell et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients
Silvia C. Formenti et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
T follicular regulatory cells suppress Tfh-mediated B cell help and synergistically increase IL-10-producing B cells in breast carcinoma
Hongsheng Song et al.
IMMUNOLOGIC RESEARCH (2019)
CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration
Hana Triki et al.
LIFE SCIENCES (2019)
siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion
Worapol Ngamcherdtrakul et al.
TRANSLATIONAL RESEARCH (2019)
Regulatory T Cells Control the Switch From in situ to Invasive Breast Cancer
Leandro M. Martinez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Lack of Robust Prognostic Biomarkers for Immunotherapy in Breast Cancer-Adverse Ev Reply
Sylvia Adams et al.
JAMA ONCOLOGY (2019)
LBA21KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
J Cortés et al.
ANNALS OF ONCOLOGY (2019)
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer A Phase 1 Study
Leisha A. Emens et al.
JAMA ONCOLOGY (2019)
A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia
Yongxian Hu et al.
BONE MARROW TRANSPLANTATION (2019)
Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin
Simone L. Park et al.
NATURE (2019)
Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG
Yan Gu et al.
NATURE MEDICINE (2019)
Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis
Sasagu Kurozumi et al.
ONCOLOGY LETTERS (2019)
If we build it they will come: targeting the immune response to breast cancer
Margaret E. Gatti-Mays et al.
NPJ BREAST CANCER (2019)
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
Colt A. Egelston et al.
JCI INSIGHT (2019)
Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer
Soizic Garaud et al.
JCI INSIGHT (2019)
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
Aura Muntasell et al.
CLINICAL CANCER RESEARCH (2019)
Tumor-infiltrating human CD4(+) regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity
Mojgan Ahmadzadeh et al.
SCIENCE IMMUNOLOGY (2019)
The combined presence of CD20+B cells and PD-L1+tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome
H. Arias-Pulido et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Human T Cell Development, Localization, and Function throughout Life
Brahma V. Kumar et al.
IMMUNITY (2018)
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas et al.
NATURE MEDICINE (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer
Joe Yeong et al.
FRONTIERS IN IMMUNOLOGY (2018)
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation
Pradip Bajgain et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated Cytotoxicity
Antoun Al Absi et al.
CANCER RESEARCH (2018)
GLOBOCAN 2018: counting the toll of cancer
[Anonymous]
LANCET (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Luc Y. Dirix et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer
Lea Lowenfeld et al.
ONCOIMMUNOLOGY (2017)
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study
Stephen J. Luen et al.
LANCET ONCOLOGY (2017)
Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours
J. Justin Milner et al.
NATURE (2017)
The correlation of CD19+CD24+CD38+B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients
Mohammad Kazzem Gheybi et al.
BREAST CANCER (2017)
Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer
In Hae Park et al.
ONCOTARGET (2017)
Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites
Brahma V. Kumar et al.
CELL REPORTS (2017)
Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients
Tullia C. Bruno et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
Therapeutic blockade of Foxp3 in experimental breast cancer models
Mariela A. Moreno Ayala et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer
Joe Yeong et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer
Shicheng Su et al.
CELL RESEARCH (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Prognostic Factors for Breast Cancer: an Immunomorphological Update
Luca Roncati et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients
Carlo Fremd et al.
ONCOIMMUNOLOGY (2016)
CD103 and Intratumoral Immune Response in Breast Cancer
Zhi-Qiang Wang et al.
CLINICAL CANCER RESEARCH (2016)
Correlation between serum level of chemokine (C-C motif) ligand 18 and poor prognosis in breast cancer
J. H. Sun et al.
GENETICS AND MOLECULAR RESEARCH (2016)
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
Elizabeth A. Mittendorf et al.
ONCOTARGET (2016)
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton et al.
JAMA ONCOLOGY (2016)
Overexpression of IL-15 promotes tumor destruction via NK1.1+cells in a spontaneous breast cancer model
Amy E. Gillgrass et al.
BMC CANCER (2015)
Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome
Cheng Xu et al.
BMC CANCER (2015)
Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance
Elizabeth M. Steinert et al.
CELL (2015)
Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10
Huimin Tao et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade
Elizabeth Buchbinder et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
CD8+ CD103+ Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
Faycal Djenidi et al.
JOURNAL OF IMMUNOLOGY (2015)
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity
Yaron Carmi et al.
NATURE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade
Philipp Mueller et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
Hallie Wimberly et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Association between CD8+T-cell infiltration and breast cancer survival in 12 439 patients
H. R. Ali et al.
ANNALS OF ONCOLOGY (2014)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
Ping Shen et al.
NATURE (2014)
Reprogramming Tumor-Infiltrating Dendritic Cells for CD103+CD8+ Mucosal T-cell Differentiation and Breast Cancer Rejection
Te-Chia Wu et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
David Masopust et al.
JOURNAL OF IMMUNOLOGY (2014)
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast
Aseem Lal et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
Monica Bodogai et al.
CANCER RESEARCH (2013)
Peripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets
Emilie Mamessier et al.
JOURNAL OF IMMUNOLOGY (2013)
Inhibition of Breast Cancer Metastasis by Resveratrol-Mediated Inactivation of Tumor-Evoked Regulatory B Cells
Catalina Lee-Chang et al.
JOURNAL OF IMMUNOLOGY (2013)
Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells
Cara N. Skon et al.
NATURE IMMUNOLOGY (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis
Miki Takenaka et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
The prognostic significance of B lymphocytes in invasive carcinoma of the breast
S. M. A. Mahmoud et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
Chun-Jian Qi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Antigen-Independent Differentiation and Maintenance of Effector-like Resident Memory T Cells in Tissues
Kerry A. Casey et al.
JOURNAL OF IMMUNOLOGY (2012)
Natural killer cells act as rheostats modulating antiviral T cells
Stephen N. Waggoner et al.
NATURE (2012)
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M. Levin et al.
NATURE (2012)
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
Andrew J. Rech et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis
Natalie A. Carter et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Human NK cell lytic granules and regulation of their exocytosis
Konrad Krzewski et al.
FRONTIERS IN IMMUNOLOGY (2012)
CTLA-4 Blockade following Relapse of Malignancy after Allogeneic Stem Cell Transplantation Is Associated with T Cell Activation But Not with Increased Levels of T Regulatory Cells
Jiehua Zhou et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
Purevdorj B. Olkhanud et al.
CANCER RESEARCH (2011)
Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression
Qiao Li et al.
CLINICAL CANCER RESEARCH (2011)
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller et al.
CYTOTHERAPY (2011)
RADIATION ENHANCES REGULATORY T CELL REPRESENTATION
Evelyn L. Kachikwu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Human Perforin Employs Different Avenues to Damage Membranes
Tilen Praper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation
Vivien Beziat et al.
JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: Dendritic Cell-Restricted Antigen Presentation Initiates the Follicular Helper T Cell Program but Cannot Complete Ultimate Effector Differentiation
Radhika Goenka et al.
JOURNAL OF IMMUNOLOGY (2011)
Environmental and Antigen Receptor-Derived Signals Support Sustained Surveillance of the Lungs by Pathogen-Specific Cytotoxic T Lymphocytes
Young-Tae Lee et al.
JOURNAL OF VIROLOGY (2011)
Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-γ on activation
Andrea De Maria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Memory CD8(+) T cell differentiation
Joshua J. Obar et al.
YEAR IN IMMUNOLOGY 2 (2010)
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Cyril Fauriat et al.
BLOOD (2010)
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Niklas K. Bjorkstrom et al.
BLOOD (2010)
Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
Andrew L. Doedens et al.
CANCER RESEARCH (2010)
2-Gy whole-body irradiation significantly alters the balance of CD4+CD25- T effector cells and CD4+CD25+Foxp3+ T regulatory cells in mice
Yanyan Qu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells
Matthew E. Pipkin et al.
IMMUNITY (2010)
Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
CD69 Suppresses Sphingosine 1-Phosophate Receptor-1 (S1P1) Function through Interaction with Membrane Helix 4
Alexander J. Bankovich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment
Nathalie T. Joncker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
Christopher J. Chan et al.
JOURNAL OF IMMUNOLOGY (2010)
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab
Aruna Mani et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies
Tanios S. Bekaii-Saab et al.
MOLECULAR CANCER THERAPEUTICS (2009)
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody et al.
BREAST CANCER RESEARCH (2009)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
Jessica Marlind et al.
CLINICAL CANCER RESEARCH (2008)
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells
Baldev Vasir et al.
JOURNAL OF IMMUNOLOGY (2008)
TLR-activated B cells suppress T cell-mediated autoimmunity
Vicky Lampropoulou et al.
JOURNAL OF IMMUNOLOGY (2008)
Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
Alessandra Beano et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers
Inge Marie Svane et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
Brian J. Czerniecki et al.
CANCER RESEARCH (2007)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Competence and competition:: the challenge of becoming a long-lived plasma cell
Andreas Radbruch et al.
NATURE REVIEWS IMMUNOLOGY (2006)
IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
M Ahmadzadeh et al.
BLOOD (2006)
Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses
SH Wei et al.
NATURE IMMUNOLOGY (2005)
Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis
D Keefe et al.
IMMUNITY (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2
R Gennari et al.
CLINICAL CANCER RESEARCH (2004)
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies:: Analysis of sustained interferon γ production in a subset of patients
R Parihar et al.
CLINICAL CANCER RESEARCH (2004)
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions
L Ohl et al.
IMMUNITY (2004)
Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
IM Svane et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
M Akdis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Regulation of CD103 expression by CD8(+) T cells responding to renal allografts
DH Wang et al.
JOURNAL OF IMMUNOLOGY (2004)
B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells:: Role of TGF-β1
VV Parekh et al.
JOURNAL OF IMMUNOLOGY (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Prevention of arthritis by interleukin 10-producing B cells
C Mauri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Maintenance of serological memory by polyclonal activation of human memory B cells
NL Bernasconi et al.
SCIENCE (2002)
Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast
JA Coronella et al.
JOURNAL OF IMMUNOLOGY (2002)
The interaction properties of costimulatory molecules revisited
AV Collins et al.
IMMUNITY (2002)
Protection from respiratory virus infections can be mediated by antigen-specific CD4+ T cells that persist in the lungs
RJ Hogan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Preferential localization of effector memory cells in nonlymphoid tissue
D Masopust et al.
SCIENCE (2001)
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
ME Brunkow et al.
NATURE GENETICS (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
